President and CEO of Exact Sciences Corp (30-Year Financial, Insider Trades) Kevin T Conroy (insider trades) sold 13,875 shares of EXAS on 02/27/2020 at an average price of $80.27 a share. The total sale was $1.1 million.
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Sciences Corp has a market cap of $11.98 billion; its shares were traded at around $80.95 with and P/S ratio of 12.19. Exact Sciences Corp had annual average EBITDA growth of 6.20% over the past five years. GuruFocus has detected 3 severe warning signs with Exact Sciences Corp. .
CEO Recent Trades:
- President and CEO Kevin T Conroy sold 13,875 shares of EXAS stock on 02/27/2020 at the average price of $80.27. The price of the stock has increased by 0.85% since.
- President and CEO Kevin T Conroy sold 18,115 shares of EXAS stock on 02/25/2020 at the average price of $85.11. The price of the stock has decreased by 4.89% since.
CFO Recent Trades:
- CFO Jeffrey Thomas Elliott sold 1,627 shares of EXAS stock on 02/27/2020 at the average price of $80.27. The price of the stock has increased by 0.85% since.
- CFO Jeffrey Thomas Elliott sold 4,910 shares of EXAS stock on 02/25/2020 at the average price of $85.11. The price of the stock has decreased by 4.89% since.
Directors and Officers Recent Trades:
- President, Cologuard Mark Stenhouse sold 1,051 shares of EXAS stock on 02/27/2020 at the average price of $80.27. The price of the stock has increased by 0.85% since.
- General Manager - Diagnostics G Bradley Cole sold 27,356 shares of EXAS stock on 02/19/2020 at the average price of $100. The price of the stock has decreased by 19.05% since.
- General Manager, New Ventures Jacob A Orville sold 1,153 shares of EXAS stock on 02/19/2020 at the average price of $100.68. The price of the stock has decreased by 19.6% since.
For the complete insider trading history of EXAS, click here
.
